ARCHIVES

Flat Centers Budget Irks House Subcommittee; Porter Repeats Call For Funding Bypass Budget

This article is from The Cancer Letter archive.

Vol. 16 No. 12 | March 23, 1990

Download PDF Visit The Full Archive

Related Articles

Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent

January 27, 2012

Also FDA clarifies data requirements for phase I IND applications.

April 29, 2005

In Brief: Monaco, Yarbro Named To Pharmacopeial Board; Gene Therapy Trial For ADA Clears First Hurdle

March 23, 1990

Panel Resumes Deliberations

January 4, 1980

FDA Ceases Exclusion Of Women From Early Drug Studies

May 7, 1993

Correction: Appropriations Reports Included Language of Minorities and Underserved

October 15, 1999